About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Financial and Employment Issues in Acute Leukemia Survivors
By
Nandita Khera
58 views
November 9, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
22:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…
Feat.
T. Badar
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
50:34
Scripps MD Anderson Cancer Center
The Cure of Leukemias in the Next Decade: An Optimist’s View
Feat.
H. Kantarjian
19:10
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center
Feat.
H. Kantarjian
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
Feat.
C. Lai
27:28
UChicago Medicine
AML: Current Treatment Landscape and Key Recent Updates
Feat.
A. Patel
16:59
MyCancerHaven
Experts Discuss Current and Future Management of AML
Feat.
R. Vij,
N. Daver
28:07
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymph…
Feat.
W. Stock
06:49
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Mini-Hyper-CVD Plus Venetoclax for Older Ad…
Feat.
M. Luskin
16:27
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Update on CHIP and CCUS
Feat.
L. Weeks
04:11
Total Health
ASCO 2022 Updates in Leukemia and MDS
Feat.
D. Sallman
11:02
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Asciminib Combined With Dasatinib and Predn…
Feat.
M. Luskin
19:51
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
A 50-Year Personal Perspective on the Treatment of AML
Feat.
C. Schiffer
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Chronic GVHD: A Case-Based Discussion
Feat.
L. Perry
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
37:03
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: ALL
Feat.
E. Jabbour
31:00
Louisville Hematology Highlights
Current Approaches in the Frontline Treatment of Adult ALL
Feat.
N. Short
28:57
Total Health
Highlights From Key Hematology Trials at ASCO® 2023
Feat.
J. Strauss
27:47
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…
Feat.
I. Amanam